Brief: Xilio Therapeutics Announces Pricing Of Underwritten Offering
12/02/2026 02:45
Feb 12 (Reuters) - Xilio Therapeutics Inc XLO.O: XILIO THERAPEUTICS ANNOUNCES PRICING OF UNDERWRITTEN OFFERING XILIO THERAPEUTICS INC - GROSS PROCEEDS FROM OFFERING ARE EXPECTED TO BE APPROXIMATELY $40.0 MILLION Source text: ID:nGNX59tztk Further company coverage: XLO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xilio Therapeutics
See all newsXilio Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Xilio Therapeutics Inc expected to post a loss of 92 cents a share - Earnings Preview
Brief: Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
U.S. STOCKS ON THE MOVE-Palantir, AeroVironment, Valvoline
U.S. STOCKS ON THE MOVE-Medtronic, AeroVironment, Tesla